Your browser doesn't support javascript.
loading
A lost track in ICHD 3 beta: A comprehensive review on osmophobia.
Zanchin, Giorgio; Fuccaro, Matteo; Battistella, Pierantonio; Ermani, Mario; Mainardi, Federico; Maggioni, Ferdinando.
Afiliação
  • Zanchin G; 1 Interdepartmental Headache Centre, School of Medicine, University of Padua, Padua, Italy.
  • Fuccaro M; 1 Interdepartmental Headache Centre, School of Medicine, University of Padua, Padua, Italy.
  • Battistella P; 1 Interdepartmental Headache Centre, School of Medicine, University of Padua, Padua, Italy.
  • Ermani M; 1 Interdepartmental Headache Centre, School of Medicine, University of Padua, Padua, Italy.
  • Mainardi F; 2 Headache Centre, Neurological Division, SS Giovanni e Paolo Hospital, Venice, Italy.
  • Maggioni F; 1 Interdepartmental Headache Centre, School of Medicine, University of Padua, Padua, Italy.
Cephalalgia ; 38(2): 340-352, 2018 02.
Article em En | MEDLINE | ID: mdl-27919021
ABSTRACT
Background Osmophobia (Os) has been reported to be much more prevalent in migraine (M) than in other primary headaches, and its high specificity in the differential diagnosis between M and tension-type headache (TTH) has been reported. Os was included in the ICHD II Appendix as a diagnostic criterion of M. It disappeared in ICHD-3 beta. To understand this choice, we reviewed the literature after 2004. Methods This was a systematic review. We searched in PubMed, MEDLINE and Cochrane library for "osmophobia", "odour/odorphobia AND headache", "odour/odor hypersensitivity AND headache" and "olfactory hypersensitivity AND headache". Results 112 papers cited Os as an accompanying symptom of headache; 16 focused on Os in M diagnosis. With the data from 40 articles, we calculated the pooled prevalence of Os in 14,360 patients (2281 pediatric) affected by M (n = 12,496) and TTH (n = 1864). In M, the prevalence was 48.5% (CI 95% 41.4 to 55.8%) in adults and 23.4% (CI 95% 15.7 to 33.4%) in pediatric patients; in TTH, the prevalence was 8.9% (CI 95% 4.6 to 13.5%) in adults and 7.9% (CI 95% 3.3 to 18.1%) in pediatric patients. Ten of these papers allowed us to calculate the sensibility and specificity of Os in differential diagnosis between M and TTH. In adults, the value of specificity was 94.1% (CI 95% 88.9 to 96.9%), and sensitivity was 51.4% (CI 95% 38.4 to 64.2%). In pediatric patients, specificity was 92.0% (CI 95% 81.9 to 96.7%), and sensitivity was 22.1% (CI 95% 10.1 to 41.8%). Conclusion The literature endorses the inclusion of Os among M diagnostic criteria. On this ground, the decision to remove Os from ICHD 3 beta appears unjustified and a revision of this choice is recommended.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Fóbicos / Classificação Internacional de Doenças / Transtornos do Olfato / Transtornos de Enxaqueca Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Fóbicos / Classificação Internacional de Doenças / Transtornos do Olfato / Transtornos de Enxaqueca Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article